Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary (33) Apply Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Summaries of opinion Remove Summaries of opinion filter Paediatric investigation plans Remove Paediatric investigation plans filter Orphan designations Remove Orphan designations filter Direct healthcare professional communication Remove Direct healthcare professional communication filter Withdrawn applications (27) Apply Withdrawn applications filter Referrals (7) Apply Referrals filter

Product number

Patient safety

Yes (6) Apply Yes filter

Authorisation status

Authorised (311) Apply Authorised filter Refused (1) Apply Refused filter Withdrawn (54) Apply Withdrawn filter

ATC code

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

Opinion status

Positive (6) Apply Positive filter

Application type

Initial authorisation (2) Apply Initial authorisation filter Post-authorisation (4) Apply Post-authorisation filter

PIP decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) (6) Apply P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) filter PM: decision on the application for modification of an agreed PIP (43) Apply PM: decision on the application for modification of an agreed PIP filter W: decision granting a waiver in all age groups for all conditions or indications (13) Apply W: decision granting a waiver in all age groups for all conditions or indications filter

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

From:

To:

PIP compliance check

Yes (13) Apply Yes filter

Compliance procedure number

Orphan designation – intended use

Orphan decision number

Orphan designation status

Positive (49) Apply Positive filter

Medicine type

Accelerated assessment Remove Accelerated assessment filter Conditional approval Remove Conditional approval filter Generic Remove Generic filter Additional monitoring (701) Apply Additional monitoring filter Biosimilar (93) Apply Biosimilar filter Exceptional circumstances (75) Apply Exceptional circumstances filter Orphan medicine (483) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

501 results

Remove all filtersRemove all filters

Categories Human Remove Human filter

Medicine Orphan designations Remove Orphan designations filter Paediatric investigation plans Remove Paediatric investigation plans filter Direct healthcare professional communication Remove Direct healthcare professional communication filter Summaries of opinion Remove Summaries of opinion filter European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter

Medicine type Generic Remove Generic filter Conditional approval Remove Conditional approval filter Accelerated assessment Remove Accelerated assessment filter

Sort by

List item

Human medicine European public assessment report (EPAR): Exviera (updated)

dasabuvir sodium, Hepatitis C, Chronic
Date of authorisation: 14/01/2015, , Revision: 25, Authorised, Last updated: 12/08/2022
List item

Human medicine European public assessment report (EPAR): Vaxzevria (previously COVID-19 Vaccine AstraZeneca) (updated)

ChAdOx1-SARS-COV-2, COVID-19 virus infection
Date of authorisation: 29/01/2021, , , , Revision: 23, Authorised, Last updated: 12/08/2022
List item

Human medicine European public assessment report (EPAR): Kalydeco (updated)

ivacaftor, Cystic Fibrosis
Date of authorisation: 23/07/2012, , Revision: 33, Authorised, Last updated: 10/08/2022
List item

Human medicine European public assessment report (EPAR): Comirnaty (updated)

Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2, COVID-19 virus infection
Date of authorisation: 21/12/2020, , , , Revision: 27, Authorised, Last updated: 10/08/2022
List item

Human medicine European public assessment report (EPAR): Pemetrexed medac (updated)

pemetrexed, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 26/11/2015, , Revision: 8, Authorised, Last updated: 09/08/2022
List item

Human medicine European public assessment report (EPAR): Myclausen (updated)

mycophenolate mofetil, Graft Rejection
Date of authorisation: 07/10/2010, , Revision: 15, Authorised, Last updated: 04/08/2022
List item

Human medicine European public assessment report (EPAR): Clopidogrel Viatris (previously Clopidogrel Taw Pharma) (updated)

clopidogrel besilate, Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 16/10/2009, , Revision: 26, Authorised, Last updated: 03/08/2022
List item

Human medicine European public assessment report (EPAR): Clopidogrel / Acetylsalicylic acid Mylan (updated)

acetylsalicylic acid, clopidogrel hydrogen sulfate, Acute Coronary Syndrome; Myocardial Infarction
Date of authorisation: 09/01/2020, , Revision: 4, Authorised, Last updated: 02/08/2022
List item

Human medicine European public assessment report (EPAR): Posaconazole AHCL (updated)

posaconazole, Mycoses
Date of authorisation: 25/07/2019, , Revision: 4, Authorised, Last updated: 01/08/2022
List item

Human medicine European public assessment report (EPAR): Enhertu (updated)

trastuzumab deruxtecan, Breast Neoplasms
Date of authorisation: 18/01/2021, , , Revision: 6, Authorised, Last updated: 01/08/2022
List item

Human medicine European public assessment report (EPAR): Nuvaxovid (updated)

SARS-CoV-2 recombinant spike protein, COVID-19 virus infection
Date of authorisation: 20/12/2021, , , Revision: 3, Authorised, Last updated: 01/08/2022
List item

Human medicine European public assessment report (EPAR): Entecavir Mylan (updated)

entecavir monohydrate, Hepatitis B
Date of authorisation: 18/09/2017, , Revision: 5, Authorised, Last updated: 29/07/2022
List item

Human medicine European public assessment report (EPAR): Entecavir Accord (updated)

Entecavir, Hepatitis B, Chronic
Date of authorisation: 25/09/2017, , Revision: 5, Authorised, Last updated: 29/07/2022
List item

Human medicine European public assessment report (EPAR): Tigecycline Accord (updated)

Tigecycline, Soft Tissue Infections; Intraabdominal Infections; Bacterial Infections; Skin Diseases, Infectious
Date of authorisation: 17/04/2020, , Revision: 4, Authorised, Last updated: 29/07/2022
List item

Human medicine European public assessment report (EPAR): Tegsedi (updated)

inotersen sodium, Amyloidosis
Date of authorisation: 06/07/2018, , , , Revision: 11, Authorised, Last updated: 28/07/2022
List item

Human medicine European public assessment report (EPAR): Amversio (updated)

betaine, Homocystinuria
Date of authorisation: 05/05/2022, , , Authorised, Last updated: 28/07/2022
List item

Human medicine European public assessment report (EPAR): Libtayo (updated)

Cemiplimab, Carcinoma, Squamous Cell
Date of authorisation: 28/06/2019, , , Revision: 12, Authorised, Last updated: 28/07/2022
List item

Human medicine European public assessment report (EPAR): Jcovden (previously COVID-19 Vaccine Janssen) (updated)

adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S), COVID-19 virus infection
Date of authorisation: 11/03/2021, , , , Revision: 22, Authorised, Last updated: 28/07/2022
List item

Human medicine European public assessment report (EPAR): Pemetrexed Sandoz (updated)

pemetrexed disodium hemipentahydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 18/09/2015, , Revision: 7, Authorised, Last updated: 27/07/2022
List item

Human medicine European public assessment report (EPAR): Pemetrexed Fresenius Kabi (updated)

pemetrexed, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 22/07/2016, , Revision: 13, Authorised, Last updated: 27/07/2022
List item

Human medicine European public assessment report (EPAR): Grepid (updated)

clopidogrel (as besilate), Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 27/07/2009, , Revision: 25, Authorised, Last updated: 27/07/2022
List item

Human medicine European public assessment report (EPAR): Granpidam (updated)

sildenafil citrate, Hypertension, Pulmonary
Date of authorisation: 14/11/2016, , Revision: 7, Authorised, Last updated: 26/07/2022
List item

Human medicine European public assessment report (EPAR): Vitrakvi (updated)

larotrectinib sulfate, Abdominal Neoplasms
Date of authorisation: 19/09/2019, , , Revision: 6, Authorised, Last updated: 26/07/2022
List item

Human medicine European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna) (updated)

CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2), COVID-19 virus infection
Date of authorisation: 06/01/2021, , , , Revision: 26, Authorised, Last updated: 22/07/2022
List item

Human medicine European public assessment report (EPAR): Sugammadex Fresenius Kabi (updated)

sugammadex sodium, Neuromuscular Blockade
Date of authorisation: 15/07/2022, , Authorised, Last updated: 21/07/2022

Load more

501 results

Human medicine European public assessment report (EPAR): Exviera (updated)

Human medicine European public assessment report (EPAR): Vaxzevria (previously COVID-19 Vaccine AstraZeneca) (updated)

Human medicine European public assessment report (EPAR): Kalydeco (updated)

Human medicine European public assessment report (EPAR): Comirnaty (updated)

Human medicine European public assessment report (EPAR): Pemetrexed medac (updated)

Human medicine European public assessment report (EPAR): Myclausen (updated)

Human medicine European public assessment report (EPAR): Clopidogrel Viatris (previously Clopidogrel Taw Pharma) (updated)

Human medicine European public assessment report (EPAR): Clopidogrel / Acetylsalicylic acid Mylan (updated)

Human medicine European public assessment report (EPAR): Posaconazole AHCL (updated)

Human medicine European public assessment report (EPAR): Enhertu (updated)

Human medicine European public assessment report (EPAR): Nuvaxovid (updated)

Human medicine European public assessment report (EPAR): Entecavir Mylan (updated)

Human medicine European public assessment report (EPAR): Entecavir Accord (updated)

Human medicine European public assessment report (EPAR): Tigecycline Accord (updated)

Human medicine European public assessment report (EPAR): Tegsedi (updated)

Human medicine European public assessment report (EPAR): Amversio (updated)

Human medicine European public assessment report (EPAR): Libtayo (updated)

Human medicine European public assessment report (EPAR): Jcovden (previously COVID-19 Vaccine Janssen) (updated)

Human medicine European public assessment report (EPAR): Pemetrexed Sandoz (updated)

Human medicine European public assessment report (EPAR): Pemetrexed Fresenius Kabi (updated)

Human medicine European public assessment report (EPAR): Grepid (updated)

Human medicine European public assessment report (EPAR): Granpidam (updated)

Human medicine European public assessment report (EPAR): Vitrakvi (updated)

Human medicine European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna) (updated)

Human medicine European public assessment report (EPAR): Sugammadex Fresenius Kabi (updated)